This inventor holds 4 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: Takeda San Diego, Inc., Pfizer Corporation. Active years: 2007-2026.
Company Filing History:
Years Active: 2007-2026
Title: Oleg Brodsky: Innovator in Crystallization Technologies
Introduction
Oleg Brodsky is a notable inventor based in San Diego, CA. He has made significant contributions to the field of crystallization, particularly in relation to various biological compounds. With a total of 4 patents, his work has implications in both research and pharmaceutical applications.
Latest Patents
Brodsky's latest patents include the "Crystallization of AKT3," which provides crystals relating to AKT3 and its various uses. Another significant patent is the "Crystallization of 11-Beta-Hydroxysteroid Dehydrogenase type 1," which also offers crystals related to this enzyme and its various applications. These innovations highlight his expertise in crystallization techniques and their potential benefits in medical research.
Career Highlights
Throughout his career, Oleg Brodsky has worked with prominent companies such as Takeda San Diego, Inc. and Pfizer Corporation. His experience in these leading pharmaceutical firms has allowed him to develop and refine his skills in the field of crystallization.
Collaborations
Brodsky has collaborated with notable coworkers, including Eric Adam and Mark Knuth. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.
Conclusion
Oleg Brodsky's contributions to the field of crystallization are noteworthy, with several patents that have the potential to impact medical research and applications. His work exemplifies the importance of innovation in the scientific community.